1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics
出版年份 2018 全文链接
标题
1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics
作者
关键词
Diabetic kidney disease, Metabolomics, 1,5-Anhydroglucitol
出版物
Metabolomics
Volume 14, Issue 4, Pages -
出版商
Springer Nature
发表日期
2018-02-27
DOI
10.1007/s11306-018-1337-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency
- (2018) Adriana Mika et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism
- (2017) Hua Chen et al. JOURNAL OF PROTEOME RESEARCH
- Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease
- (2017) Gearoid M. McMahon et al. KIDNEY INTERNATIONAL
- Metabolomics for clinical use and research in chronic kidney disease
- (2017) Berthold Hocher et al. Nature Reviews Nephrology
- Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study
- (2016) Eugene P. Rhee et al. AMERICAN JOURNAL OF NEPHROLOGY
- Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes
- (2016) Jueun Lee et al. CLINICA CHIMICA ACTA
- Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease
- (2016) Menglu Liang et al. DIABETES CARE
- Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans
- (2016) Mariam El Assar et al. JOURNAL OF PHYSIOLOGY-LONDON
- Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin
- (2016) Christoph Hasslacher et al. Journal of Diabetes
- Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
- (2016) Hua Chen et al. Redox Biology
- Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease
- (2015) Ying-Yong Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Ability of 1,5-Anhydro-d-glucitol Values to Predict Coronary Artery Disease in a Non-Diabetic Population
- (2015) Nobutaka Ikeda et al. International Heart Journal
- Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels
- (2015) O. Kovamees et al. JOURNAL OF INTERNAL MEDICINE
- A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population
- (2015) P. Sekula et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease
- (2015) Katryna Cisek et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A metabolomic profile is associated with the risk of incident coronary heart disease
- (2014) Anika A.M. Vaarhorst et al. AMERICAN HEART JOURNAL
- Ultra-performance liquid chromatography–mass spectrometry as a sensitive and powerful technology in lipidomic applications
- (2014) Ying-Yong Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry
- (2014) Ying-Yong Zhao et al. CLINICAL BIOCHEMISTRY
- Association of 1,5-Anhydroglucitol with Diabetes and Microvascular Conditions
- (2014) E. Selvin et al. CLINICAL CHEMISTRY
- Serum Metabolomic Profiling and Incident CKD among African Americans
- (2014) B. Yu et al. Clinical Journal of the American Society of Nephrology
- 1,5-Anhydro-d-glucitol predicts coronary artery disease prevalence and complexity
- (2014) Nobutaka Ikeda et al. Journal of Cardiology
- Association of reduced levels of serum 1,5-Anhydro-d-glucitol with carotid atherosclerosis in patients with type 2 diabetes
- (2014) Takao Sato et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
- (2014) Monika A. Niewczas et al. KIDNEY INTERNATIONAL
- Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease
- (2014) Esther Nkuipou-Kenfack et al. PLoS One
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Arginase inhibition alleviates hypertension in the metabolic syndrome
- (2013) Hany M El-Bassossy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metabolomics in chronic kidney disease
- (2013) Ying-Yong Zhao CLINICA CHIMICA ACTA
- Plasma and Urinary Amino Acid Metabolomic Profiling in Patients with Different Levels of Kidney Function
- (2013) F. Duranton et al. Clinical Journal of the American Society of Nephrology
- Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
- (2013) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
- (2013) E. P. Rhee et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Metabolites associate with kidney function decline and incident chronic kidney disease in the general population
- (2013) Oemer-Necmi Goek et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3–4 Chronic Kidney Disease Patients
- (2013) Henricus A. M. Mutsaers et al. PLoS One
- Serum Metabolite Concentrations and Decreased GFR in the General Population
- (2012) Oemer-Necmi Goek et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy
- (2012) Akiyoshi Hirayama et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus
- (2012) Alexey Shemyakin et al. CIRCULATION
- Plasma Metabolomic Profiles in Different Stages of CKD
- (2012) V. O. Shah et al. Clinical Journal of the American Society of Nephrology
- Selective Endothelial Overexpression of Arginase II Induces Endothelial Dysfunction and Hypertension and Enhances Atherosclerosis in Mice
- (2012) Boris L. Vaisman et al. PLoS One
- Diabetes-induced vascular dysfunction involves arginase I
- (2011) Maritza J. Romero et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Serum 1,5-anhydro-d-glucitol levels predict first-ever cardiovascular disease: An 11-year population-based Cohort study in Japan, the Suita study
- (2011) M. Watanabe et al. ATHEROSCLEROSIS
- ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial
- (2011) S.M. Titan et al. CLINICAL NEPHROLOGY
- Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction
- (2011) W. J. Kim et al. DIABETES CARE
- Metabolomics in the study of kidney diseases
- (2011) Robert H. Weiss et al. Nature Reviews Nephrology
- Metabolomic profiling of uremic solutes in CKD patients
- (2010) Takafumi Toyohara et al. HYPERTENSION RESEARCH
- Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline
- (2009) Xiu-Fen Ming et al. BMC Cardiovascular Disorders
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now